589 related articles for article (PubMed ID: 15104191)
21. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
Przybilla B; Ring J; Griesshammer B; Braun-Falco O
Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
[TBL] [Abstract][Full Text] [Related]
22. The sting challenge test in Hymenoptera venom allergy: pros and cons.
Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
[TBL] [Abstract][Full Text] [Related]
23. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
[TBL] [Abstract][Full Text] [Related]
25. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
26. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
Kochuyt AM; Van Hoeyveld EM; Stevens EA
Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
[TBL] [Abstract][Full Text] [Related]
28. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of allergy to insect stings in children, with and without venom immunotherapy.
Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
N Engl J Med; 2004 Aug; 351(7):668-74. PubMed ID: 15306668
[TBL] [Abstract][Full Text] [Related]
30. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
Tavares B; Rordigues F; Pereira C; Loureiro G; Chieira C
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
[TBL] [Abstract][Full Text] [Related]
31. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
[TBL] [Abstract][Full Text] [Related]
32. Natural history of Hymenoptera venom allergy in Eastern Spain.
Fernandez J; Soriano V; Mayorga L; Mayor M
Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
[TBL] [Abstract][Full Text] [Related]
33. Insect sting allergy with negative venom skin test responses.
Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
J Allergy Clin Immunol; 2001 May; 107(5):897-901. PubMed ID: 11344359
[TBL] [Abstract][Full Text] [Related]
34. [Therapy control of specific hymenoptera venom allergy].
Aust W; Wichmann G; Dietz A
Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
[TBL] [Abstract][Full Text] [Related]
35. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
36. Sublingual desensitization in patients with wasp venom allergy: preliminary results.
Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
Int J Immunopathol Pharmacol; 2008; 21(3):669-77. PubMed ID: 18831935
[TBL] [Abstract][Full Text] [Related]
37. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
[No Abstract] [Full Text] [Related]
38. [Allergic reactions to insect bites].
Urbanek R
Ther Umsch; 1989 Sep; 46(9):654-62. PubMed ID: 2678576
[TBL] [Abstract][Full Text] [Related]
39. The value of immunotherapy with venom in children with allergy to insect stings.
Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
[TBL] [Abstract][Full Text] [Related]
40. [Preventive treatment of severe allergic complications caused by Hymenoptera venom. Our experience apropos of 250 cases].
Nataf P; Benitah E; Guinnepain MT; Herman D
Ann Med Interne (Paris); 1985; 136(8):625-8. PubMed ID: 3833008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
